Radioiodine-Refractory Thyroid Cancer – Is it Time to Change the Definition in the Light of Novel Redifferentiation Therapies?

Name: Radioiodine-Refractory Thyroid Cancer – Is it Time to Change the Definition in the Light of Novel Redifferentiation Therapies?
Start: 2025-04-04T13:30:00+02:00
End: 2025-04-04T14:30:00+02:00

Event Categories:

Clinical Nuclear Medicine, Live Webinars

April 4, 2025 – 13:30 – 14:30 CEST

more information coming soon

Pre-register now

Registration will open in 2025. Pre-register now to be among the first to receive updates on the start date!

Pre-register now

Faculty

Speaker

Event Overview

ESMIT

View Organiser Website

esmit@eanm.org

Event Navigation

« Theranostic Training for Technologists
Focus on Benign Thyroid Disease: From Thyroid Nodule to Hyperthyroidism and Immune Disease »